Journal for ImmunoTherapy of Cancer (Nov 2021)
156 RBC-derived, activating antigen carriers (SQZ AACs) prime potent T cell responses and drive tumor regression in vivo
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)